Navigation Links
Glivec Enhances Survival Rates In Leukemia

Glivec, a drug used to treat chronic myeloid leukemia has shown to improve the survival rates in 90 percent of patients with the cancer.// The National Institute for health and Clinical Excellence (NICE), which regulates drug approvals in the UK had only wanted to approve Glivec for advanced cases, but the drug has not proved itself in clinical trials.

CML is a common form of blood cancer, which arises due to a defect in the production of white blood cells. Glivec targets only the affected molecules and leaves the healthy ones unaffected. But it is an expensive drug and costs at least £14,000 per patient per year.

Results from the IRIS study showed that 93 percent of patients taking the drug in early stages did not progress to advanced stage. Also 83 percent had good survival rate of five years. Before the introduction of Glivec, CML had poor prognosis with survival rates of only four to six years.

Sandy Craine, from CML Support, who took part in the trial said, "I never would have believed I would be standing here today. Glivec helped save my life and I am grateful that I can pass on this message of hope to others diagnosed with this once devastating disease."

Professor Charles Craddock, director of Stem Cell Transplant Unit, Queen Elizabeth Hospital, Birmingham, added, "The significant success of Glivec in treating CML is an exciting model for the development of new treatments for other cancers."
'"/>




Page: 1

Related medicine news :

1. Glivec - New Hope For CMC Patients
2. Glivec the hot cancer drug from Novartis
3. Animal Fat Enhances Risk Of Stomach
4. Tiagabine Enhances Sleep Maintenance In Insomnia Patients
5. Simulated Heart Tissue Enhances Understanding of Arrhythmias And Defibrillator Failure
6. Study Claims That Chemo Before And After Surgery Enhances Survival Rates
7. Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs
8. Haryana Enhances Nutritional Support for Women, Children
9. Loop Incision Treatment Enhances Premature Delivery Risk
10. Long-Term Survival can be Predicted by a Simple Lung Test
11. Hepatitis G May Boost HIV Survival
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... Pensacola, FL (PRWEB) , ... April 28, 2017 ... ... Tampa, Florida are conducting a pilot study of ActiGraph’s CentrePoint Data ... ActiGraph is a leading provider of clinical-grade wearable activity and sleep monitoring solutions ...
(Date:4/28/2017)... ... April 28, 2017 , ... NuevaCare, a leading home care ... Millbrae, Burlingame, and Palo Alto, is proud to announce information upgrades to its blog ... and read organized content on topics such as home care (generally) as well as ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement to create ... by the continuing support of the Jane and Leonard Korman Family Foundation. The ...
(Date:4/27/2017)... ... April 27, 2017 , ... The American ... 2017 Public Leadership in Neurology Award (PLINA). The couple joins a prestigious list ... Vice President Walter Mondale, actor Michael J. Fox and former U.S. Attorney General ...
(Date:4/27/2017)... ... , ... Offering the purest product of its kind, Swissx Labs AG has ... than the market has seen before. Swissx uses proprietary strains of hemp plants grown ... process for extraction, to produce its CBD oil--maximizing its benefits for health and wellness. ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ... & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... , Chief Executive Officer of the Company is scheduled to present ... Richard Bear and the Chairman of the Board, Tony ... ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... BOSTON , April 19, 2017  New research provides ... with advanced Parkinson,s, according to a study released today that ... 69th Annual Meeting in Boston , ... comes to the treatment of Parkinson,s disease, the oral drug ... of life and longevity. But as the disease progresses, the ...
Breaking Medicine Technology: